{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:51:12Z","timestamp":1720417872621},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.annemergmed.2004.12.013","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T07:34:19Z","timestamp":1111476859000},"page":"614-619","source":"Crossref","is-referenced-by-count":23,"title":["Resuscitative Effect of a \u03b3-Aminobutyric Acid B Receptor Antagonist on \u03b3-Hydroxybutyric Acid Mortality in Mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Mauro A.M.","family":"Carai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"Gessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2004.12.013_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug \u03b3-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol Sci."},{"key":"10.1016\/j.annemergmed.2004.12.013_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM200101113440202","article-title":"Adverse events including death, associated with the use of 1,4-butanediol","volume":"344","author":"Zvosec","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1553-2712.2002.tb02154.x","article-title":"Gamma hydroxybutyric acid (GHB) intoxication","volume":"9","author":"Mason","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00006565-200012000-00017","article-title":"Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature","volume":"16","author":"Shannon","year":"2000","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/BF01271186","article-title":"The GABAB-receptor antagonist, CGP 35348, antagonizes \u03b3-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice","volume":"103","author":"Nissbrandt","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABAB receptors in the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid","volume":"428","author":"Carai","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1749-6632.2002.tb04187.x","article-title":"Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice","volume":"965","author":"Quang","year":"2002","journal-title":"Ann NY Acad Sci."},{"key":"10.1016\/j.annemergmed.2004.12.013_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(96)00916-8","article-title":"Binding characteristics of the gamma-hydroxybutyric acid as a weak but selective GABAB receptor antagonist","volume":"321","author":"Mathivet","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","article-title":"\u03b3-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors","volume":"38","author":"Lingenhoehl","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib10","first-page":"753","article-title":"\u03b3-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide","volume":"281","author":"Hechler","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib11","first-page":"303","article-title":"\u03b3-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo","volume":"290","author":"Gobaille","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0028-3908(02)00026-6","article-title":"GABAB receptor-mediated increase of neurosteroids by \u03b3-hydroxybutyric acid","volume":"42","author":"Barbaccia","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)01503-3","article-title":"The anxiolytic effect of \u03b3-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil","volume":"342","author":"Schmidt-Mutter","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1096\/fj.02-0846fje","article-title":"Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB)","volume":"17","author":"Andriamampandry","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0924-977X(97)00087-4","article-title":"Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice","volume":"8","author":"Martellotta","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib16","first-page":"938","article-title":"Extracellular events induced by \u03b3-hydroxybutyrate in striatum: a midrodialysis study","volume":"56","author":"Hechler","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib17","first-page":"71","article-title":"Naloxone reverses the inhibitory effect of \u03b3-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study","volume":"224","author":"Feigenbaum","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.302.1.180","article-title":"Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria)","volume":"302","author":"Gupta","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00470592","article-title":"Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes","volume":"78","author":"Liljequist","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0091-3057(90)90007-5","article-title":"Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference","volume":"37","author":"Bilsky","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-001-0951-8","article-title":"Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gamma-hydroxybutyrate in mice","volume":"160","author":"Cook","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.annemergmed.2004.12.013_bib22","series-title":"Gamma-hydroxybutyrate: Molecular, Functional and Clinical Aspects","first-page":"28","article-title":"Part of the pharmacological actions of \u03b3-hydroxybutyrate are mediated by GABAB receptors","author":"Bernasconi","year":"2002"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064404018104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064404018104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T20:06:50Z","timestamp":1549310810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064404018104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0196064404018104"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2004.12.013","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}